Home/Filings/4/0001104659-19-003716
4//SEC Filing

Garner Elizabeth 4

Accession 0001104659-19-003716

CIK 0001261249other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 5:30 PM ET

Size

10.7 KB

Accession

0001104659-19-003716

Insider Transaction Report

Form 4
Period: 2019-01-24
Garner Elizabeth
Sr. VP & Chief Medical Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2019-01-2418,56517,500 total
    Common Stock (18,565 underlying)
  • Exercise/Conversion

    Common Stock

    2019-01-24+18,56530,300 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-01-2517,5000 total
    Common Stock (17,500 underlying)
  • Exercise/Conversion

    Common Stock

    2019-01-25+17,50047,800 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]On January 24, 2018 the reporting person was granted 18,565 restricted stock units that fully vested and were delivered on January 24, 2019.
  • [F3]On January 25, 2017, the reporting person was granted 35,000 restricted stock units that vest as follows: 17,500 units vested and were delivered on January 25, 2018, and 17,500 units vested and were delivered on January 25, 2019.

Documents

1 file

Issuer

AGILE THERAPEUTICS INC

CIK 0001261249

Entity typeother

Related Parties

1
  • filerCIK 0001608578

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 5:30 PM ET
Size
10.7 KB